Characterization of the Clinical Drug-Drug Interaction Profile of VH4524184 (VH-184), a Third-Generation Integrase Strand Transfer Inhibitor

Conference Reports for NATAP

HIV Glasgow 2026
8-11 November


Characterization of the Clinical Drug-Drug Interaction Profile of VH4524184 (VH-184), a Third-Generation Integrase Strand Transfer Inhibitor

	Glasgow 2026 Nov 8-11 Glasgow: The Evolution of Integrase Strand Transfer Inhibitors: VH-184, a 3rd-Generation Inhibitor With an Enhanced Resistance Profile - (11/09/26)